# Ticagrelor Versus Clopidogrel in Carotid Artery Stenting

Study · id `cardio:ct-nct02677545` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02677545](<https://clinicaltrials.gov/study/NCT02677545>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02677545

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 210 participants.

## Technical summary

Registry record NCT02677545. Randomized; no masking; primary purpose treatment. Start 2016-12 (actual); primary completion 2022-04-28 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 210 participants (enrolled count; ClinicalTrials.gov record NCT02677545, source copy `cardio:ctgov-nct02677545-2022-06-28`, retrieved 2026-10-31)
- Started: 2016-12 (actual) (ClinicalTrials.gov record NCT02677545, source copy `cardio:ctgov-nct02677545-2022-06-28`, retrieved 2026-10-31)
- Primary completion: 2022-04-28 (actual) (ClinicalTrials.gov record NCT02677545, source copy `cardio:ctgov-nct02677545-2022-06-28`, retrieved 2026-10-31)
- Completion: 2022-04-28 (actual) (ClinicalTrials.gov record NCT02677545, source copy `cardio:ctgov-nct02677545-2022-06-28`, retrieved 2026-10-31)
- Countries: Belgium; Germany; Italy; Netherlands; Switzerland; United Kingdom (ClinicalTrials.gov record NCT02677545, source copy `cardio:ctgov-nct02677545-2022-06-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02677545-2022-06-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: Ticagrelor Versus Clopidogrel in Carotid Artery Stenting
- Acronym: PRECISE-MRI
- Condition: Carotid Artery Stenosis
- Intervention (Drug): Ticagrelor
- Intervention (Drug): Clopidogrel
- Intervention (Drug): Aspirin
- Lead sponsor: University Hospital, Basel, Switzerland
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Carotid artery stenosis (`cardio:carotid-stenosis`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: University Hospital, Basel, Switzerland (`cardio:org-university-hospital-basel-switzerland`)

## Provenance

Content hash: 61eb65d31a04dbe745d228f36487deef4ab5cbfb9f88579a695f3fce011b13dd
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
